Try our mobile app
JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
(“JSE”)
DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY
SECRETARY AND THE JSE LTIS 2018 TRUST
The JSE LTIS 2018 Trust (“Trust”) has acquired 781 870 JSE ordinary shares
in the open market on behalf of executive directors, prescribed officers,
the Company Secretary, and senior members of staff (“LTIS 2018
participants”) in respect of share awards granted in March 2024 to these
LTIS 2018 participants under the JSE’s Long-Term Incentive Scheme (“LTIS
2018”). The ordinary shares are held by the LTIS 2018 participants on a
direct beneficial basis.
These ordinary shares are restricted until all vesting criteria are
fulfilled whereupon the shares will vest in the hands of LTIS 2018
participants. To the extent that the vesting criteria are not fulfilled,
the share awards are forfeited.
The vesting of these restricted JSE ordinary shares is subject to –
(i) the JSE achieving specified corporate performance targets over the
measurement period; and
(ii) the LTIS 2018 participant remaining in the employ of the JSE for the
vesting term (collectively “the vesting criteria”).
These JSE ordinary shares were acquired on-market, with prior clearance and
at a volume-weighted average price (“VWAP”) of R89.61 per ordinary share.
The total transaction value amounted to R70 061 395. The daily high, low
and volume-weighted average price for the various transactions effected by
the Trust were –
Dates in 2024 Daily VWAP of
Number of JSE Daily highest Daily lowest
that JSE JSE shares
ordinary price paid price paid
ordinary acquired
shares (cents per (cents per
shares were (cents per
acquired share) share)
acquired share)
18 March 193 624 8851.36 8855 8765
19 March 117 683 9146.27 9206 8948
20 March 470 563 8959.36 9250 8964
The requisite approvals have been granted by shareholders at the JSE’s
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these ordinary shares.
ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS
AND THE COMPANY SECRETARY
Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, the prescribed officers and the
Company Secretary have, on 20 March 2024, accepted grants of restricted JSE
ordinary shares, as reflected below.
Total number
Total Rand value
of restricted
of restricted JSE
JSE ordinary Nature of
Executive Role ordinary shares
shares interest
awarded and
awarded and
accepted
accepted
Group CEO &
Direct
L Fourie Executive 148 310 13 290 059
beneficial
Director
Group CFO &
Direct
F Suliman Executive 60 080 5 383 768
beneficial
Director
Prescribed Direct
A Greenwood 58 398 5 233 044
Officer beneficial
Prescribed Direct
V Lee 31 082 2 785 258
Officer beneficial
Prescribed Direct
I Monale 45 394 4 067 756
Officer beneficial
Prescribed Direct
Q Mthembu 20 830 1 866 576
Officer beneficial
Prescribed Direct
M Randall 49 144 4 403 793
Officer beneficial
Prescribed Direct
T Tsoaeli 40 804 3 656 446
Officer beneficial
Prescribed Direct
V Reddy 64 886 5 814 434
Officer beneficial
Group Company Direct
GA Brookes 16 040 1 437 344
Secretary beneficial
The restricted shares will vest in two tranches, one-half on 1 March 2027
and the remaining half on 1 March 2028, subject to the vesting criteria as
set out above being met.
The individual allocations (grant and acceptance) were approved by the JSE’s
Group Remuneration Committee and clearance to deal was granted by the
Chairman of the Board.
Sandton
22 March 2024
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
